Larotinib mesylate hydrate | MedChemExpress (MCE)
Larotinib mesylate hydrate is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC50 of 0.6 nM[1].
| Trivial name | Larotinib mesylate hydrate |
| Catalog Number | HY-153110A |
| Research Area | Cancer |
| CAS# | 2097129-93-4 |
| Purity | 98.66% |
| SMILES | COC(C(OCCCN1C[C@]2([H])[C@](OCCO2)([H])C1)=C3)=CC4=C3C(NC5=CC(Cl)=C(C=C5)F)=NC=N4.CS(=O)(O)=O.CS(=O)(O)=O.O |
| PubChem Chemical Structure ID | 168006954 |
| Size | 100 mg |
| Supplier Page | https://www.medchemexpress.com/larotinib-mesylate-hydrate.html |